Preprint / Version 1

A Shift in Reality: Schizophrenia and Visual processing

##article.authors##

  • Amay Malhotra Polygence Student

DOI:

https://doi.org/10.58445/rars.208

Keywords:

schizophrenia, visual processing, visual impairments, autonomic nervous system, hallucinations, delusions, transduction

Abstract

Schizophrenia is a severe mental illness in which false beliefs and reality are confused by an individual. The illness can affect more than a person's social difficulty; the disorder can cause individual several hardships. On another note, processing visual information is key in allowing organisms to navigate their environment, as it creates conscious awareness for social interaction and personal activities. In patients with schizophrenia, it has been established that impairments in visual processing exist and contribute to symptoms of the disorder. These visual impairments are misperceptions of real, external stimuli in their environment. Individuals with schizophrenia experience visual processing issues (i.e., issues with transduction), such as blurred vision and hypersensitivity. They can additionally experience hallucinations, which can be caused by irregular neurotransmitter flow. This can distort an existing stimulus or cause the perception of an entity that is not even there. The significance of these findings is to highlight possible dysfunction in neural networking regarding the visual processing of schizophrenic patients and to encourage future correlational studies on the topic.

References

Bhugra, D. (2005). The global prevalence of schizophrenia. PLoS medicine, 2(5), e151. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020151

Dold, M., Samara, M. T., Li, C., Tardy, M., & Leucht, S. (2015). Haloperidol versus first‐generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. Cochrane Database of Systematic Reviews, (1). https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009831.pub2/full

Hartling, L., Abou-Setta, A. M., Dursun, S., Mousavi, S. S., Pasichnyk, D., & Newton, A. S. (2012). Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis. Annals of internal medicine, 157(7), 498-511.

https://www.acpjournals.org/doi/full/10.7326/0003-4819-157-7-201210020-00525

Health Line Media (2021, April 1). MNT investigates: Second-generation antipsychotic drugs for schizophrenia. Medical News Today. Retrieved April 21, 2023, from https://www.medicalnewstoday.com/articles/schizophrenia-second-generation-antipsychotics

Khan, S. (2022). How Do First-Generation Antipsychotics Work? Rx List. https://www.rxlist.com/antipsychotics_first_generation/drug-class.htm

Kulhara, P., Shah, R., & Grover, S. (2009). Is the course and outcome of schizophrenia better in the ‘developing’world?. Asian Journal of Psychiatry, 2(2), 55-62.

https://www.sciencedirect.com/science/article/abs/pii/S1876201809000306

Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009). Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. The Lancet, 373(9657), 31-41.

Leucht, S., Komossa, K., Rummel-Kluge, C., Corves, C., Hunger, H., Schmid, F., ... & Davis, J. M. (2009). A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. American Journal of Psychiatry, 166(2), 152-163. https://ajp.psychiatryonline.org/doi/abs/10.1176/appi.ajp.2008.08030368

Liu, T., Zhang, L., Pang, L., Li, N., Chen, G., & Zheng, X. (2015). Schizophrenia-related disability in China: prevalence, gender, and geographic location. Psychiatric Services, 66(3), 249-257. https://ps.psychiatryonline.org/doi/full/10.1176/appi.ps.201400032

https://www.sciencedirect.com/science/article/abs/pii/S014067360861764X

Maatz, A., Hoff, P., & Angst, J. (2022). Eugen Bleuler's schizophrenia—a modern perspective. Dialogues in clinical neuroscience. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421899/

National Eye Institute (April 20, 2022). “How the Eyes Work.” https://www.nei.nih.gov/learn-about-eye-health/healthy-vision/how-eyes-work

Pacific, W., & Hasan, S. A. W. “Schizophrenia.” World Health Organization. https://www.who.int/news-room/fact-sheets/detail/schizophrenia

Padma, T. V. (2014). Developing countries: The outcomes paradox. Nature, 508(7494), S14-S15. https://www.nature.com/articles/508S14a

Patel, K. R., Cherian, J., Gohil, K., & Atkinson, D. (2014). Schizophrenia: overview and treatment option s. Pharmacy and Therapeutics, 39(9), 638. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159061/

Stogios, N., Gdanski, A., Gerretsen, P., Chintoh, A. F., Graff-Guerrero, A., Rajji, T. K., ... & Agarwal, S. M. (2021). Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health. npj Schizophrenia, 7(1), 22.

https://www.nature.com/articles/s41537-021-00151-6

Teeple, R. C., Caplan, J. P., & Stern, T. A. (2009). Visual hallucinations: differential diagnosis and treatment. Primary care companion to the Journal of clinical psychiatry, 11(1), 26. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660156/#:~:text=Psychosis%20(schizophrenia%2Fschizoaffective%20disorder).&text=Visual%20hallucinations%20have%20been%20reported,with%20schizophrenia%20and%20schizoaffective%20disorder.

Downloads

Posted

2023-06-02